Article Text


Initial experience with Thrombotest
  1. A. L. Miller,
  2. G. Farrer-Brown,
  3. J. Pether
  1. Courtauld Institute of Biochemistry, Middlesex Hospital Medical School, London


    The initial experience of using Thrombotest instead of Quick's one-stage prothrombin time to control anticoagulant therapy is described.

    Patients well controlled by the Quick test are often found to be over-anticoagulated by Thrombotest standards, so the introduction of Thrombotest has led to widespread reductions in dosage. No improvement in stability of control has been noted. The main advantages of Thrombotest seem to be its technical simplicity and the comparability of results obtained in different laboratories.

    Statistics from

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.